共 54 条
Antibody Effector Functions Mediated by Fcγ-Receptors Are Compromised during Persistent Viral Infection
被引:57
作者:
Wieland, Andreas
[1
,2
]
Shashidharamurthy, Rangaiah
[3
]
Kamphorst, Alice O.
[1
,2
]
Han, Jin-Hwan
[1
,2
]
Aubert, Rachael D.
[1
,2
]
Choudhury, Biswa P.
[5
]
Stowell, Sean R.
[3
]
Lee, Junghwa
[1
,2
]
Punkosdy, George A.
[1
,2
]
Shlomchik, Mark J.
[4
]
Selvaraj, Periasamy
[3
]
Ahmed, Rafi
[1
,2
]
机构:
[1] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
[4] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA
[5] Univ Calif San Diego, La Jolla, CA 92093 USA
来源:
基金:
美国国家卫生研究院;
关键词:
LYMPHOCYTIC CHORIOMENINGITIS VIRUS;
IMMUNE-COMPLEX DISEASE;
T-CELL RESPONSES;
IN-VIVO;
B-CELLS;
ANTITUMOR ACTIVITIES;
DENDRITIC CELLS;
BREAST-CANCER;
STEM-CELLS;
THERAPY;
D O I:
10.1016/j.immuni.2015.01.009
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
T cell dysfunction is well documented during chronic viral infections but little is known about functional abnormalities in humoral immunity. Here we report that mice persistently infected with lymphocytic choriomeningitis virus (LCMV) exhibit a severe defect in Fc gamma-receptor (Fc gamma R)-mediated antibody effector functions. Using transgenic mice expressing human CD20, we found that chronic LCMV infection impaired the depletion of B cells with rituximab, an anti-CD20 antibody widely used for the treatment of B cell lymphomas. In addition, Fc gamma R-dependent activation of dendritic cells by agonistic anti-CD40 antibody was compromised in chronically infected mice. These defects were due to viral antigen-anti-body complexes and not the chronic infection per se, because Fc gamma R-mediated effector functions were normal in persistently infected mice that lacked LCMV-specific antibodies. Our findings have implications for the therapeutic use of antibodies and suggest that high levels of pre-existing immune complexes could limit the effectiveness of antibody therapy in humans.
引用
收藏
页码:367 / 378
页数:12
相关论文